EHA 2015: The treatment of relapsed/refractory chronic lymphocytic leukemia - 101793

Spotlight
Video

EHA 2015: The treatment of relapsed/refractory chronic lymphocytic leukemia

VJHemOnc has 1040 videos Subscribe Here

Loading........
Description: Barbara Eichhorst, MD, of the University of Cologne, Cologne, Germany, summarises her highlights of the 20th Congress of the European Hematology Association (EHA), including the results of a phase 1b trial that showed the combination of venetoclax (ABT-199/GDC-0199) and rituximab induces deep responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL); and the long-term follow-up results of a trial that evaluated the safety and clinical activity of idelalisib in patients with relapsed or refractory CLL.

—————

The Video Journal of Hematological Oncology (VJHemOnc) is an independent, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve understanding and awareness of hematological malignancies.

Website: http://www.vjhemonc.com/...
Twitter: https://twitter.com/VJHemOn...
Facebook: https://www.facebook.com/vj...
LinkedIn: https://www.linkedin.com/co...
Shared By : VJHemOnc
Posted on : 07/14/15
Added : 3 years ago